Dragonfly Therapeutics and Bristol Myers Squibb Announce Exclusive Global License for Dragonfly’s IL-12 Investigational Immunotherapy ProgramBusiness Wire • 08/17/20
Bristol Myers Squibb and the Bristol Myers Squibb Foundation Commit $300 Million to Accelerate and Expand Health Equity and Diversity and Inclusion EffortsBusiness Wire • 08/12/20
Bristol Myers Reports Cancer Drug Test Success; BMY Stock Nears Buy PointInvestors Business Daily • 08/11/20
Bristol-Myers Squibb Company (BMY) CEO Giovanni Caforio on Q2 2020 Results - Earnings Call TranscriptSeeking Alpha • 08/06/20
Bristol Myers lifts annual profit view on hopes of pickup in patient visits to doctorsReuters • 08/06/20
A Dangerous Dividend Blue-Chip You Should Ignore And A Great Alternative That's Set To SoarSeeking Alpha • 08/05/20
Is a Surprise Coming for Bristol-Myers (BMY) This Earnings Season?Zacks Investment Research • 08/05/20